Form 4 for SLS SELLAS Life Sciences Group, Inc.
Accepted 2022-12-05 00:00:00 ET · period of report 2022-12-05 · accession 0001104659-22-124566 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-05 | 2022-12-05 | SLS | Burns John Thomas | CAO, Senior VP, Fin | S - Sale | $2.59 | -1,159 | 29.3K | -4% | -$3,002 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-12-05 | S | D | 1,159 | $2.59 | 29,347 | D | — | — | (F1) Represents the number shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. |